Literature DB >> 11346463

Cell-free entry of human T-cell leukemia virus type 1 to mouse cells.

R Feng1, A Kabayama, K Uchida, H Hoshino, M Miwa.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent for adult T-cell leukemia and HTLV-1-associated myelopathy / tropical spastic paraparesis. Recently we infected newborn mice by inoculating HTLV-1-producing human cells, and found that T-cells, B-cells and granulocytes were infected in vivo. To understand the mechanism of viral-cell interaction and the pathogenesis of HTLV-1 using the mouse model, it is important to clarify the cellular tropism using a cell-free HTLV-1 transmission system. We employed a highly transmissible cell-free HTLV-1 produced by a feline kidney cell line, c77, and studied the susceptibility of 9 kinds of mouse cell lines, EL4, RLm1, CTLL-2, J774.1, DA-1, Ba / F3, WEHI-3, NIH3T3 and B1, and two kinds of human cell lines, Molt-4 and Hut78. HTLV-1 proviral sequence was found by PCR in all 9 mouse cell lines as well as in 2 human cell lines and viral entry was blocked with sera from an HTLV-1 carrier and an adult T-cell leukemia patient. Unexpectedly, mouse cell lines EL4 and RLm1 and human cell lines Molt-4 and Hut78 showed similar efficiency for viral entry. These results suggest a wide distribution of HTLV-1 receptor in mouse cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346463      PMCID: PMC5926731          DOI: 10.1111/j.1349-7006.2001.tb01110.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  41 in total

1.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

Review 2.  The HTLV-I envelope glycoproteins: structure and functions.

Authors:  L Delamarre; A R Rosenberg; C Pique; D Pham; I Callebaut; M C Dokhélar
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996

3.  Integration of HTLV-1 provirus into mouse transforming growth factor-alpha gene.

Authors:  J Fang; S Kushida; R Feng; M Tanaka; H Kikukawa; T Kawamura; K Uchida; M Miwa
Journal:  Biochem Biophys Res Commun       Date:  1997-04-28       Impact factor: 3.575

4.  Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism.

Authors:  J H Pierce; P P Di Fiore; S A Aaronson; M Potter; J Pumphrey; A Scott; J N Ihle
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

5.  Oral infection of a common marmoset with human T-cell leukemia virus type-I (HTLV-I) by inoculating fresh human milk of HTLV-I carrier mothers.

Authors:  K Kinoshita; K Yamanouchi; S Ikeda; S Momita; T Amagasaki; H Soda; M Ichimaru; R Moriuchi; S Katamine; T Miyamoto
Journal:  Jpn J Cancer Res       Date:  1985-12

6.  Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus with lymphopenia and hypocomplementaemia.

Authors:  M Noguchi; M Iwamori; T Hirano; S Kobayashi; H Hashimoto; S Hirose; Y Nagai
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

7.  Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.

Authors:  A Jinno; Y Haraguchi; H Shiraki; H Hoshino
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  Clonal extinction of myelomonocytic leukemic cells by serum from mice injected with endotoxin.

Authors:  D Metcalf
Journal:  Int J Cancer       Date:  1980-02-15       Impact factor: 7.396

9.  Identification of membrane antigens important for adsorption of human T-cell leukaemia virus type I.

Authors:  D X Fu; Y Haraguchi; A Jinno; D Yang; H Hoshino
Journal:  Res Virol       Date:  1998 Nov-Dec

10.  Syncytium formation by recombinant HTLV-II envelope glycoprotein.

Authors:  Q X Li; D Camerini; Y Xie; M Greenwald; D R Kuritzkes; I S Chen
Journal:  Virology       Date:  1996-04-01       Impact factor: 3.616

View more
  4 in total

Review 1.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

Review 2.  Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.

Authors:  Michael D Lairmore; Rajaneesh Anupam; Nadine Bowden; Robyn Haines; Rashade A H Haynes; Lee Ratner; Patrick L Green
Journal:  Viruses       Date:  2011-07-12       Impact factor: 5.048

3.  The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice.

Authors:  Mineki Saito; Reiko Tanaka; Hideki Fujii; Akira Kodama; Yoshiaki Takahashi; Toshio Matsuzaki; Hiroshi Takashima; Yuetsu Tanaka
Journal:  Retrovirology       Date:  2014-08-28       Impact factor: 4.602

4.  Cell-free human T-cell leukemia virus type 1 binds to, and efficiently enters mouse cells.

Authors:  Binlian Sun; Takayuki Nitta; Momoko Shoda; Masakazu Tanaka; Shuji Hanai; Hiroo Hoshino; Masanao Miwa
Journal:  Jpn J Cancer Res       Date:  2002-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.